Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. ARGX
4. HD
5. FN
6. METC
7. TSLA
8. XP
9. SNOW
10. KLAR

Go back to Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
(NASDAQ: LEXX) Delayed: 10.80 +0.48 (4.65%)
Previous Close $10.32    52 Week High $ 
Open $10.18    52 Week Low $ 
Day High $11.01    P/E N/A 
Day Low $10.18    EPS $ 
Volume 5,795